US Broker Ratings

Waters Corporation (WAT) Stock Analysis: Unlocking a 24.41% Upside Potential for Healthcare Investors

Waters Corporation (NYSE: WAT) stands out in the healthcare sector’s diagnostics and research industry, offering promising opportunities for investors. With a market capitalization of $30.42 billion, this Massachusetts-based company is..

Roivant Sciences Ltd. (ROIV) Stock Analysis: Exploring a Potential 30% Upside in Healthcare Biotech

Roivant Sciences Ltd. (NASDAQ: ROIV) stands as a formidable player in the healthcare sector, particularly within the biotechnology industry. Based in London, the company has a market capitalization of $19.62..

Alkermes plc (ALKS) Investor Outlook: Analyzing a 32.80% Upside Potential Amidst a Challenging Year

Alkermes plc (NASDAQ: ALKS) presents an interesting investment opportunity within the healthcare sector, particularly in the drug manufacturing niche focusing on specialty and generic drugs. Headquartered in Dublin, Ireland, Alkermes..

DexCom, Inc. (DXCM) Stock Analysis: 41% Potential Upside Drives Investor Interest

DexCom, Inc. (DXCM) is a prominent player in the healthcare sector, particularly within the medical devices industry. With a market capitalization of $23.76 billion, this San Diego-based company stands out..

Hologic, Inc. (HOLX) Stock Analysis: Steady Healthcare Innovator with Limited Upside Potential

Hologic, Inc. (NASDAQ: HOLX), a leading player in the medical instruments and supplies industry, is a prominent name in the healthcare sector. With a market capitalization of $16.97 billion, the..

TG Therapeutics, Inc. (TGTX) Stock Analysis: Unveiling a 21.71% Upside Potential in the Biotech Space

TG Therapeutics, Inc. (NASDAQ: TGTX), a promising player in the biopharmaceutical landscape, continues to captivate investor interest with its dynamic approach to treating B-cell mediated diseases. With a market capitalization..

BridgeBio Pharma, Inc. (BBIO) Stock Analysis: A Deep Dive into its 37.18% Potential Upside

BridgeBio Pharma, Inc. (NASDAQ: BBIO) presents a compelling opportunity for investors looking to capitalize on the burgeoning biotechnology sector. With a market cap of $14.21 billion, this Palo Alto-based biopharmaceutical..

Bruker Corporation (BRKR) Stock Analysis: Exploring a 28% Potential Upside in the Medical Devices Sector

Bruker Corporation (NASDAQ: BRKR), a prominent player within the healthcare sector focusing on medical devices, presents an intriguing opportunity for investors seeking substantial growth potential. With its market capitalization of..

Viatris Inc. (VTRS) Stock Analysis: Exploring Potential Gains with a 7.76% Upside

Investors eyeing the healthcare sector may find Viatris Inc. (NASDAQ: VTRS) an intriguing prospect, especially with a potential upside of 7.76% based on the current average target price of $15.72...

Biogen Inc. (BIIB) Stock Analysis: Exploring a 15% Potential Upside Amidst Evolving Healthcare Dynamics

Biogen Inc. (BIIB), a prominent player in the healthcare sector, primarily operates within the drug manufacturing industry, focusing on developing and delivering therapies for a range of neurological and autoimmune..

ICON plc (ICLR) Stock Analysis: Unveiling a 29.27% Potential Upside Amidst a Transformative Era in Clinical Research

ICON plc (NASDAQ: ICLR) stands at the forefront of the healthcare diagnostics and research industry, with a commanding presence in clinical research organization services. Headquartered in Dublin, Ireland, ICON provides..

Globus Medical, Inc. (GMED)

⚠️ No article content returned.

..

Universal Health Services, Inc. (UHS) Stock Analysis: Exploring a 41.87% Potential Upside

Universal Health Services, Inc. (NYSE: UHS) stands as a formidable player in the healthcare sector, specifically within the medical care facilities industry. With a market capitalization of $10.64 billion, the..

Grifols, S.A. (GRFS) Stock Analysis: Is a 37% Upside Within Reach?

Grifols, S.A. (NASDAQ: GRFS), a significant player in the healthcare sector, primarily operates within the drug manufacturing industry. With a market capitalization of $5.5 billion, the Spanish company is a..

Axsome Therapeutics, Inc. (AXSM) Investor Outlook: Unpacking a 20% Potential Upside Amidst Robust CNS Pipeline

Axsome Therapeutics, Inc. (NASDAQ: AXSM) is a prominent player in the biotechnology sector, focusing on the development of novel therapies for central nervous system (CNS) disorders. With a market capitalization..

Qiagen N.V. (QGEN) Stock Analysis: Exploring a 40% Potential Upside for Investors

Investors looking to dive into the healthcare sector may find Qiagen N.V. (NASDAQ: QGEN) an intriguing opportunity. With a market cap of $7.92 billion, Qiagen stands as a formidable player..

ResMed Inc. (RMD) Stock Analysis: 32.97% Potential Upside Captivates Investors

ResMed Inc. (NYSE: RMD), a stalwart in the healthcare sector, specifically within the medical instruments and supplies industry, is drawing attention from investors with its promising potential upside of 32.97%...

Alcon Inc. (ALC) Stock Analysis: 24.91% Potential Upside Makes This Healthcare Giant Worth Watching

Alcon Inc. (NYSE: ALC), a Swiss-based leader in the healthcare sector, particularly in medical instruments and supplies, is capturing investor attention with its remarkable growth potential. With a market capitalization..

Takeda Pharmaceutical (TAK) Stock Analysis: Strong Upside Potential with a 22.97% Increase in Sight

Takeda Pharmaceutical Company Limited (NYSE: TAK), a titan in the healthcare sector, offers a compelling opportunity for investors seeking exposure to the pharmaceutical industry. With a market capitalization of $52.54..

Stevanato Group S.p.A. (STVN) Stock Analysis: Exploring a 52.79% Potential Upside for Investors

In the ever-evolving landscape of the healthcare sector, Stevanato Group S.p.A. (NYSE: STVN) stands out as a compelling player in the medical instruments and supplies industry. Headquartered in Piombino Dese,..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds